Trial
NCT00882583
A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Bristol-Myers Squibb
Condition
Head and Neck Cancer
Intervention
Cetuximab
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-09